Elebrato Ellipta
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Elebrato Ellipta, covering 2025-05-06 to 2025-05-06. Get the full timeline:
Most recent: EMA Authorised: Elebrato Ellipta (fluticasone furoate;umeclidinium bromide;vilanterol trifenatate) — GlaxoSmithKline Trading Services Limited